Literature DB >> 22104113

Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes.

Ellaine Salvador1, Florian Wagenlehner, Christian-Daniel Köhler, Alexander Mellmann, Jörg Hacker, Catharina Svanborg, Ulrich Dobrindt.   

Abstract

Asymptomatic bacteriuria (ABU) is a condition where bacteria stably colonize the urinary tract, in a manner closely resembling commensalism at other mucosal sites. The patients carry >10(5) CFU/ml for extended periods of time and rarely develop symptoms. Contrasting the properties of ABU strains to those of uropathogenic isolates causing symptomatic infection is therefore highly relevant to understand mechanisms of bacterial adaptation. The prototype ABU strain Escherichia coli 83972 has a smaller genome than uropathogenic E. coli (UPEC) strains with deletions or point mutations in several virulence genes, suggesting that ABU strains undergo a programmed reductive evolution within human hosts. This study addressed if these observations can be generalized. Strains causing ABU in outpatients or hospitalized patients after catheterization or other invasive procedures were compared to commensal E. coli isolates from the intestinal flora of healthy individuals. Notably, clonal complex 73 (CC73) was a prominent phylogenetic lineage dominated by ABU isolates. ABU isolates from outpatients and hospitalized patients had a similar overall virulence gene repertoire, which distinguished them from many commensals, but typical UPEC virulence genes were less frequently attenuated in hospital strains than in outpatient strains or commensals. The decreased virulence potential of outpatient ABU isolates relative to that of ABU strains from hospitalized patients supports the hypothesis that loss of expression or decay of virulence genes facilitates long-term carriage and adaptation to host environments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104113      PMCID: PMC3264318          DOI: 10.1128/IAI.06191-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

Review 1.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 2.  Catheter-associated urinary tract infections.

Authors:  J W Warren
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 3.  Strategies for studying bacterial adhesion in vivo.

Authors:  H Leffler; W Agace; S Hedges; R Lindstedt; M Svensson; C Svanborg
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuries.

Authors:  R A Hull; D C Rudy; I E Wieser; W H Donovan
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children.

Authors:  K Plos; H Connell; U Jodal; B I Marklund; S Mårild; B Wettergren; C Svanborg
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  Interleukin-8 and the neutrophil response to mucosal gram-negative infection.

Authors:  W W Agace; S R Hedges; M Ceska; C Svanborg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence.

Authors:  P Andersson; I Engberg; G Lidin-Janson; K Lincoln; R Hull; S Hull; C Svanborg
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Bacteriuria in representative population samples of persons aged 72-79 years.

Authors:  G Nordenstam; V Sundh; K Lincoln; A Svanborg; C S Edén
Journal:  Am J Epidemiol       Date:  1989-12       Impact factor: 4.897

9.  Virulence properties of Escherichia coli strains in patients with chronic pyelonephritis.

Authors:  R Fünfstück; H Tschäpe; G Stein; H Kunath; M Bergner; G Wessel
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

10.  Genetic control of the variable innate immune response to asymptomatic bacteriuria.

Authors:  Jenny Grönberg-Hernández; Jenny Grönberg Hernández; Fredrik Sundén; John Connolly; Catharina Svanborg; Björn Wullt
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

View more
  26 in total

1.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Escherichia coli sequence type 73 as a cause of community acquired urinary tract infection in men and women in Rio de Janeiro, Brazil.

Authors:  Ana Paula de Souza da-Silva; Viviane Santos de Sousa; Natacha Martins; Rubens Clayton da Silva Dias; Raquel Regina Bonelli; Lee W Riley; Beatriz Meurer Moreira
Journal:  Diagn Microbiol Infect Dis       Date:  2017-02-07       Impact factor: 2.803

Review 3.  Evolutionary causes and consequences of bacterial antibiotic persistence.

Authors:  Erik Bakkeren; Médéric Diard; Wolf-Dietrich Hardt
Journal:  Nat Rev Microbiol       Date:  2020-05-27       Impact factor: 60.633

4.  Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.

Authors:  Amelia K Boehme; Andre D Kumar; Adrianne M Dorsey; James E Siegler; Monica S Aswani; Michael J Lyerly; Dominique J Monlezun; Alexander J George; Karen C Albright; Timothy M Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-08-15       Impact factor: 2.136

Review 5.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Genotypic Characterization of Virulence Factors in Escherichia coli Isolated from Patients with Acute Cystitis, Pyelonephritis and Asymptomatic Bacteriuria.

Authors:  Mohsen Tabasi; Mohammad Reza Asadi Karam; Mehri Habibi; Ehsan Mostafavi; Saeid Bouzari
Journal:  J Clin Diagn Res       Date:  2016-12-01

7.  Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Authors:  Dagmara I Kisiela; Matthew Radey; Sandip Paul; Stephen Porter; Kseniya Polukhina; Veronika Tchesnokova; Sofiya Shevchenko; Diana Chan; Maliha Aziz; Timothy J Johnson; Lance B Price; James R Johnson; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

8.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Authors:  James R Johnson; Veronika Tchesnokova; Brian Johnston; Connie Clabots; Pacita L Roberts; Mariya Billig; Kim Riddell; Peggy Rogers; Xuan Qin; Susan Butler-Wu; Lance B Price; Maliha Aziz; Marie-Hélène Nicolas-Chanoine; Chitrita Debroy; Ari Robicsek; Glen Hansen; Carl Urban; Joanne Platell; Darren J Trott; George Zhanel; Scott J Weissman; Brad T Cookson; Ferric C Fang; Ajit P Limaye; Delia Scholes; Sujay Chattopadhyay; David C Hooper; Evgeni V Sokurenko
Journal:  J Infect Dis       Date:  2013-01-03       Impact factor: 5.226

9.  Bacterial control of host gene expression through RNA polymerase II.

Authors:  Nataliya Lutay; Ines Ambite; Jenny Grönberg Hernandez; Gustav Rydström; Bryndís Ragnarsdóttir; Manoj Puthia; Aftab Nadeem; Jingyao Zhang; Petter Storm; Ulrich Dobrindt; Björn Wullt; Catharina Svanborg
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

10.  Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities.

Authors:  Allison R Eberly; Connor J Beebout; Ching Man Carmen Tong; Gerald T Van Horn; Hamilton D Green; Madison J Fitzgerald; Shuvro De; Emily K Apple; Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean; Douglass B Clayton; Charles W Stratton; Jonathan E Schmitz; Maria Hadjifrangiskou
Journal:  J Mol Biol       Date:  2019-11-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.